The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds for to support natural history studies for rare diseases and conditions. These studies are intended to provide acceptable data to the FDA that will substantially contribute to the approval of new products, or new indications for already…
We are glad to announce today (December 14th 2021) the official launch of the Joint Transnational Call 2022, a funding opportunity for research projects on the development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases. The aim of the funding opportunity is to enable scientists in different…
Similar to its upcoming Scientific Call for Proposals 2022, the French Muscular Dystrophy Association (AFM-Téléthon) will soon launch its a Medical Research Call for Proposals in Neuromuscular Disorders. Open to both French and foreign teams, the objective of the call is to support medical research projects whose aim is to improve the care and management of patients,…
Based on the results of this year’s Téléthon fund-raising event, the French Muscular Dystrophy Association (AFM-Téléthon) will soon launch its annual Call for Proposals. The Scientific Call for Proposals 2022 is open to both French and foreign teams and aims to support research with a particular focus on therapeutic and technological projects applicable to several…
Following the successful implementation of three Joint Transnational Calls since 2019, EJP RD is glad to announce the upcoming launch on December 14th of the fourth EJP RD Joint Transnational Call (JTC) 2022, aimed at funding multilateral research projects on rare diseases under the EJP-COFUND action. The aim of the call is to enable scientists…
We are glad to pre-announce the Joint Transnational Call 2022, a funding opportunity for research projects on the development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases. The aim of the funding opportunity is to enable scientists in different countries to build an effective collaboration on a…
The deadline for the EJP RD ERN Research Training Workshops funding opportunity has been extended to October 22nd. The goal of the workshops is to train researchers and clinicians affiliated to ERN- Full Members or – Affiliated Partners in relevant topics on research in rare diseases. Training themes may include innovative research methodologies, diagnostic research methodologies, interdisciplinary treatment approaches, such as gene therapy and transplantation, etc. Moreover,…
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds for fiscal years (FY) 2021 – FY 2022 to support innovative and efficient clinical trials for rare diseases and conditions. These studies are intended to provide acceptable data to the FDA that will substantially contribute to…
The ERN Research Training Workshops funding opportunity is now open for applications until October 4th. The goal of the workshops is to train researchers and clinicians affiliated to ERN- Full Members or – Affiliated Partners in relevant topics on research in rare diseases. Training themes may include innovative research methodologies, diagnostic research methodologies, interdisciplinary treatment approaches, such as gene therapy and transplantation, etc. Moreover, the workshops…
The ERA-NET Neuron Call for proposals for Transnational Research Projects on Neurodevelipmental Disorders was launched January 7 and will close March 9 14:00 CET Neurological and mental disorders impose a high societal and economic burden to the European population, leading to costs of more than 800 billion euros per year. A wide range of brain…